Showing results (161-170 of 234) with videos related to

Sort By:
Pageof 24
Leukemia|February 1, 1990
Long-term survival of patients with intermediate and high grade lymphoma treated with COMLA/ABPO I Olopade, R A Larson, R Mick, et al.
Clinical Pharmacology and Therapeutics|March 1, 1996
Etoposide combined with interferon alfa-2b: novel exploitation of established etoposide pharmacokinetics and pharmacodynamicsR Mick, E E Vokes, T M Lestingi, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1992
5-Fluorouracil, leucovorin, hydroxyurea, and escalating doses of continuous-infusion cisplatin with concomitant radiotherapy: a clinical and pharmacologic studyE E Vokes, J A Moormeier, M J Ratain, et al.
Cancer|May 1, 1997
Melanoma of unknown primary site: presentation, treatment, and prognosis--a single institution study. University of Pennsylvania Pigmented Lesion Study GroupK K Anbari, L M Schuchter, L P Bucky, et al.
American Journal of Surgery|December 1, 1990
Perioperative blood transfusion adversely affects prognosis of patients with stage I non-small-cell lung cancerA G Little, H S Wu, M K Ferguson, et al.
The Journal of Thoracic and Cardiovascular Surgery|March 1, 1986
The role of adjuvant therapy after resection of T1 N1 M0 and T2 N1 M0 non-small cell lung cancerM K Ferguson, A G Little, H M Golomb, et al.
The Annals of Thoracic Surgery|November 1, 1987
Adenosquamous lung carcinoma: clinical characteristics, treatment, and prognosisK S Naunheim, J R Taylor, C Skosey, et al.
The Journal of Thoracic and Cardiovascular Surgery|December 1, 1988
Diffusing capacity predicts morbidity and mortality after pulmonary resectionM K Ferguson, L Little, L Rizzo, et al.
Cancer|August 1, 1990
5-Fluorouracil with oral leucovorin and hydroxyurea and concomitant radiotherapy for stage III non-small cell lung cancerE E Vokes, S Vijayakumar, P C Hoffman, et al.
Cancer|August 1, 1993
Dedifferentiated chordoma. Response to aggressive chemotherapy in two casesG F Fleming, P S Heimann, J K Stephens, et al.
Pageof 24